动物治疗和诊断市场规模、份额及成长分析(按产品、技术、应用、动物类型、最终用途和地区)-产业预测,2025-2032
市场调查报告书
商品编码
1819751

动物治疗和诊断市场规模、份额及成长分析(按产品、技术、应用、动物类型、最终用途和地区)-产业预测,2025-2032

Animal Therapeutics Diagnostics Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Technology (Clinical biochemistry, Immunodiagnostics), By Application, By Animal Type, By End Use, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 192 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计 2023 年全球兽医治疗诊断市场价值将达到 473 亿美元,从 2024 年的 502.8 亿美元增长到 2032 年的 819.7 亿美元,预测期内(2025-2032 年)的复合年增长率为 6.3%。

全球动物治疗诊断市场正经历显着成长,这得益于技术创新、严格的监管标准以及对增强型动物健康解决方案日益增长的需求。关键发展包括智慧诊断系统的进步,以及专注于优化效能和改善供应链管理的人工智慧主导技术的整合。这些创新从根本上改变了动物健康数据的处理和使用方式,促进了对特定动物物种和健康状况的即时洞察,同时确保符合监管要求。机器学习和人工智慧的整合正在改善数据传播,并使行业领导者和研究人员能够实施高度精准的建议,最终推动兽医学的进步并提升整体动物福利。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二次资料和一次资料方法
  • 市场规模预测
  • 市场假设与约束

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 技术评估
  • 监管格局
  • 客户和购买标准分析

兽医治疗及诊断试剂市场规模(依产品划分)及复合年增长率(2025-2032)

  • 市场概况
  • 耗材
  • 装置

兽医治疗及诊断市场规模(依技术划分)及复合年增长率(2025-2032)

  • 市场概况
  • 临床生物化学
    • 血糖监测
    • 血气和电解质分析
    • 其他临床生物化学检验
  • 免疫诊断
    • 横向流动化验
    • ELISA
    • 免疫检测分析仪
    • 其他免疫诊断测试
  • 分子诊断
    • PCR
    • 微阵列
    • 其他分子诊断测试
  • 血液学
  • 尿液检查
  • 其他技术

兽医治疗及诊断试剂市场规模(按应用划分)及复合年增长率(2025-2032)

  • 市场概况
  • 细菌学
  • 病理
  • 寄生虫学
  • 其他用途

动物治疗及诊断市场规模(依动物类型划分)及复合年增长率(2025-2032)

  • 市场概况
  • 宠物
    • 其他伴侣动物
  • 农场动物
    • 家禽
    • 其他牲畜

动物治疗及诊断市场规模(依最终用途划分)及复合年增长率(2025-2032)

  • 市场概况
  • 兽医医院和诊所
  • 诊断实验室
  • 居家照护环境
  • 其他用途

兽医治疗及诊断市场规模(按地区划分)及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2024年)
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 按部门分類的公司份额分析
    • 收益同比比较(2022-2024 年)

主要企业简介

  • Zoetis(USA)
  • Merck Animal Health(USA)
  • Boehringer Ingelheim(Germany)
  • Elanco(USA)
  • IDEXX Laboratories(USA)
  • Virbac(France)
  • Ceva Sante Animale(France)
  • Dechra Pharmaceuticals(UK)
  • Vetoquinol(France)
  • Phibro Animal Health(USA)
  • Heska Corporation(USA)
  • Neogen(USA)
  • Covetrus(USA)
  • Thermo Fisher Scientific(USA)
  • ImmuCell(USA)
  • B. Braun Vet Care(Germany)
  • Huvepharma(Bulgaria)
  • Indian Immunologicals Limited(India)
  • Zoetis Animal Health India Pvt. Ltd.(India)
  • Inmed Animal Health(India)

结论和建议

简介目录
Product Code: SQMIG35A3116

Global Animal Therapeutics Diagnostics Market size was valued at USD 47.3 billion in 2023 and is poised to grow from USD 50.28 billion in 2024 to USD 81.97 billion by 2032, growing at a CAGR of 6.3% during the forecast period (2025-2032).

The global animal therapeutics diagnostics market is experiencing significant growth fueled by technological innovations, stringent regulatory standards, and a rising demand for enhanced animal health solutions. Key developments include the advancement of intelligent diagnostic systems and the integration of AI-driven technologies, which focus on optimizing performance and improving supply chain management. These innovations have fundamentally transformed how animal health data is processed and utilized, facilitating real-time insights tailored to specific species and health conditions while ensuring compliance with regulatory requirements. The confluence of machine learning and artificial intelligence has improved data dissemination and empowered industry leaders and researchers to implement hyper-targeted recommendations, ultimately advancing the veterinary landscape and enhancing overall animal welfare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Therapeutics Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Therapeutics Diagnostics Market Segments Analysis

Global Animal Therapeutics Diagnostics Market is segmented by Product, Technology, Application, Animal Type, End Use and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Molecular diagnostics, Hematology, Urinalysis and Other technologies. Based on Application, the market is segmented into Bacteriology, Pathology, Parasitology and Other applications. Based on Animal Type, the market is segmented into Companion animals and Farm animals. Based on End Use, the market is segmented into Veterinary hospitals and clinics, Diagnostic labs, Home care settings and Other end use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Therapeutics Diagnostics Market

The landscape of companion animals is witnessing significant growth as a global transformation in attitudes positions pets as cherished family members, particularly in regions such as North America, Europe, and Asia-Pacific. This evolving perception has propelled the animal therapeutics diagnostics market, particularly in developed countries with higher disposable incomes. Simultaneously, in developing nations, an increasing pet population is driving owners to seek enhanced care standards for their animals. This dual trend of rising demand and improved spending capacity is fostering substantial market penetration and innovation within the animal therapeutics diagnostics sector.

Restraints in the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market faces a notable constraint due to the high initial investment required for advanced therapeutics, such as biologics and cell-based therapies, alongside sophisticated diagnostic equipment. While these innovations are recognized for their remarkable efficacy and personalized outcomes, the associated costs can be a barrier, particularly for small independent veterinary clinics and in developing countries. This pricing pressure may hinder broader adoption, as smaller entities often struggle to incorporate these premium solutions. Consequently, the market's growth potential is limited, with uptake primarily concentrated among larger veterinary hospitals and research institutions unless more affordable and scalable alternatives are introduced.

Market Trends of the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market is witnessing a transformative shift driven by the burgeoning adoption of digital platforms in animal health management. This evolution is primarily fueled by the pet-tech boom and an increasing demand for enhanced diagnostic efficiency. As veterinary practices integrate smart, connected solutions, the landscape is evolving, especially within companion animal and livestock management sectors. This trend not only improves diagnostic processes but also enhances overall health management, leading to better outcomes for animals. Consequently, stakeholders in the animal health industry are focusing on innovative technologies that will redefine traditional practices and propel the market forward.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis

Global Animal Therapeutics Diagnostics Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Consumables
  • Instruments

Global Animal Therapeutics Diagnostics Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Clinical biochemistry
    • Glucose monitoring
    • Blood gas and electrolyte analysis
    • Other clinical biochemistry tests
  • Immunodiagnostics
    • Lateral flow assays
    • ELISA
    • Immunoassay analyzers
    • Other immunodiagnostic tests
  • Molecular diagnostics
    • PCR
    • Microarrays
    • Other molecular diagnostic tests
  • Hematology
  • Urinalysis
  • Other technologies

Global Animal Therapeutics Diagnostics Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Bacteriology
  • Pathology
  • Parasitology
  • Other applications

Global Animal Therapeutics Diagnostics Market Size by Animal Type & CAGR (2025-2032)

  • Market Overview
  • Companion animals
    • Dogs
    • Cats
    • Horses
    • Other companion animals
  • Farm animals
    • Cattle
    • Swine
    • Poultry
    • Other farm animals

Global Animal Therapeutics Diagnostics Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Veterinary hospitals and clinics
  • Diagnostic labs
  • Home care settings
  • Other end use

Global Animal Therapeutics Diagnostics Market Size & CAGR (2025-2032)

  • North America (Product, Technology, Application, Animal Type, End Use)
    • US
    • Canada
  • Europe (Product, Technology, Application, Animal Type, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Technology, Application, Animal Type, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Technology, Application, Animal Type, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Technology, Application, Animal Type, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Zoetis (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck Animal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elanco (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IDEXX Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ceva Sante Animale (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dechra Pharmaceuticals (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vetoquinol (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Phibro Animal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heska Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Covetrus (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ImmuCell (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Vet Care (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Huvepharma (Bulgaria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Indian Immunologicals Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis Animal Health India Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inmed Animal Health (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations